810222P

C6-NBD Glucosyl Ceramide

Avanti Research^™ - A Croda Brand 810222P, powder

• Sinónimos: N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-glucosyl-β1-1′-sphingosine
• Fórmula empírica (notación de Hill): C₃₆H₅₉N₅O₁₁
• Número de CAS: 94885-03-7
• Peso molecular: 737.88
• MDL number: MFCD00870345
• UNSPSC Code: 12352211
• NACRES: NA.25

Propiedades

• assay: >99% (TLC)
• form: powder
• packaging: pkg of 1 × 1 mg (810222P-1MG); pkg of 1 × 250 μg (810222P-250ug)
• manufacturer/tradename: Avanti Research^™ - A Croda Brand 810222P
• shipped in: dry ice
• storage temp.: −20°C

Descripción

Biochem/physiol Actions

The synthesis of glucosyl ceramide (GlcCer) occurs in the cytosolic membranes of Golgi. It is catalysed by GlcCer synthase. In the luminal Golgi membrane, GlcCer participates in the generation of glycosphingolipids. C6-NBD glcCer is useful to view ceramide rich membrane domains in Golgi compartments.

Packaging

5 mL Amber Glass Screw Cap Vial (810299P-1MG)

5 mL Clear Glass Sealed Ampule (810222P-250ug)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Información de seguridad

• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 3
• flash_point_f: No data available
• flash_point_c: No data available